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ABSTRACT 
 
Aim and objective: To determine the extent of cell damage in Pulmonary Tuberculosis 
patients with the help of comet assay. 
Study type: Prospective study. 
Place and duration of study: Tiruchengodu Govt. Hospital from September 2011 to April 
2012. 
Patients and Method: Blood samples were collected from 40 subjects [Control (Go), newly 
diagnosed TB patients (G1), Three months treated TB patients (G2), Six months treated TB 
patients (G3). n=10 subjects in each group]. Peripheral blood samples were collected, 
embedded in agrose gel, lysed in high ionic strength solution with Triton X-100, and then 
electrophoresed at pH>13, Ethidium bromide stained were then subjected to analysis under 
Fluorescent microscope. 
Result: Subjects of newly diagnosed TB (G1) patients did not show any remarkable cell 
damage as compared to control (G0). Extent of cell damage in Three months treated TB 
patients (G2) and in Six months treated TB patients (G3) was extremely significant (p 
<0.0001). From quantitative comet metrics, comet length which shows extremely significant 
difference in males compared with females. P value is <0.0003. 
Discussion: Extent of cell damage was observed significantly high in Anti-tubercular drug 
treatment patients (ie) three months treated and six months treated TB patients. Due to their 
social habits also DNA damage was significantly increased in tuberculosis patients. 
Conclusion: Dependence of drug treatment and social habits seems to be the major 
contributor of the cell damage.  
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1. INRTODUCTION 
 
                  Tuberculosis (TB) is a highly contagious infection caused by the 
bacterium called Mycobacterium tuberculosis. TB can affect anyone of any 
age. People with weakened immune systems are at increased risk. TB can 
persist for decades in infected individuals in the latent state as an 
asymptomatic disease and can emerge to cause active disease at a later stage. 
There was an  evidence that M.tuberculosis cells are exposed to DNA 
damaging agents such as reactive oxygen intermediates (ROI) and reactive 
nitrogen intermediates (RNI) generated by host macrophages. Thus, DNA 
repair pathways and the mechanisms that are involved in the maintenance of 
genome integrity appear to be an important factor for M.tuberculosis 
pathogenesis and persistence in the host. Helicases are known to play an 
important role in DNA replication, repair and recombination. Thus, helicases 
could be a potential drug target against M.tuberculosis. Understanding the role 
of these proteins could provide new insights into pathogenesis of 
M.tuberculosis in humans1. The repair of DNA damage is expected to be 
particularly important to intracellular pathogens such as M.tuberculosis, and so 
it is of interest to examine the response of M. tuberculosis to DNA damage. 
The expression of recA, a key component in DNA repair and recombination, is 
induced by DNA damage in M. tuberculosis2. 
                DNA damage accumulates with age, and genetic defects in DNA 
repair and DNA damage signaling pathways lead to symptoms of premature 
aging in humans. When DNA is damaged, our cells attempt to repair the 
damage, making use of several different types of DNA repair. Importantly, 
DNA damage and repair also lead to extensive chromatin reorganization. 
These chromatin changes can occur as far as a megabase from some forms of 
DNA damage, meaning that some types of DNA damage could affect an 
extended region of chromatin containing multiple genes3.                                                                   
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1.1)  Pulmonary tuberculosis 
 
                Pulmonary tuberculosis that affects the lungs. An infected person 
may at first feel vaguely unwell or develop a cough blamed on smoking or a 
cold. A small amount of greenish or yellow sputum may be coughed up when 
the person gets up in the morning. In time, more sputum is produced that is 
streaked with blood. Persons with pulmonary TB do not run a high fever, but 
they often have a low-grade one. They may wake up in the night drenched with 
cold sweat when the fever breaks. The patient often loses interest in food and 
may lose weight, chest pain may present. If the infection allows air to escape 
from the lungs into the chest cavity (pneumothorax) or if fluid collects in the 
pleural space (pleural effusion), the patient may have difficulty in breathing. If 
a young adult develops a pleural effusion, the chance of tubercular infection 
being the cause is very high. The TB bacilli may travel from the lungs to 
lymph nodes in the sides and back of the neck. Infection in these areas can 
break through the skin and discharge pus. Before the development of effective 
antibiotics, many patients became chronically ill with increasingly severe lung 
symptoms. They lost a great deal of weight and developed a wasted 
appearance. This outcome is uncommon today, at least where modern 
treatment methods are available4. 
                       In pulmonary tuberculosis patients, little is known about 
peripheral DNA damage, although increased oxidative stress is a well 
documented entity. Therefore, we aimed to investigate DNA damage in 
pulmonary tuberculosis patients. DNA damage was assessed by Comet assay5.  
 
                The importance of DNA damage in clinical studies would demand 
an accurate, fast and sensitive method to detect DNA damages which is also 
capable of monitoring DNA repair as well. There are several different methods 
to detect DNA damage including:  alkaline elution, clonogenic cell survival 
assay, single-cell gel electrophoresis (SCGE) and others6. The SCGE, also 
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known as comet assay, is one of the recent methods established in order to 
detect different types of DNA damage. The comet assay has been established 
as a simple, rapid, cheap, flexible and, most importantly, sensitive method to 
detect DNA damage, which is also able to detect DNA damage in individual 
cells. The concept of detecting DNA by cellular lysis was introduced in 1970s; 
however, the current and most commonly used variation of the comet assay 
(the alkaline comet assay) was developed in 1998 by Singh et al. Since 1998, 
modifications have been introduced to the assay to increase its sensitivity7 .The 
comet assay is currently used in different areas of biological sciences to detect 
DNA damage. 
     The alkaline single cell gel electrophoresis (SCG) technique is a useful tool 
for assessing DNA damage in human populations. This method has several 
advantages: a high sensitivity for detecting DNA damage expressed as single 
strand breaks and alkaline-labile sites, data from individual cells are obtained, 
the amount of blood required for this method is very small (µl), it is relatively 
easy to perform, and results are obtained in a short time . 
          It has since gained in popularity as a standard technique for evaluation 
of DNA damage/repair, biomonitoring and genotoxicity testing.  It involves 
the encapsulation of cells in a low-melting-point agarose suspension, lysis of 
the cells in neutral or alkaline (pH>13) conditions, and electrophoresis of the 
suspended lysed cells. This is  followed by  visual  analysis  with  staining  of  
DNA and  calculating  fluorescence to determine the  extent of  DNA 
damage8,9. 
            DNA strand breaks allow DNA to extend from lysed and salt-extracted 
nuclei, nucleoids, to form a comet like tail on alkaline electrophoresis. Cells 
undergoing active cell death or apoptosis demonstrate highly fragmented 
DNA. Progression of cell death results in the extensive formation of double 
strand breaks and is readily detected using alkaline electrophoretic 
conditions10.  
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                  The aim of this work is to study qualitatively the development of 
comet images evaluating extent of cellular damage and quantify different 
comet metrics.  
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 2. LITERATURE REVIEW 
 
2.1) DEFINITION 
                Tuberculosis (TB) is a potentially fatal contagious disease. It is 
caused by a bacterial micro organism, the tubercle bacillus or Mycobacterium 
tuberculosis, that affects especially the lungs but may spread to other areas (as 
the kidney or spinal column), and that is characterized by fever, cough, 
difficulty in breathing, formation of tubercles, caseation, pleural effusions, and 
fibrosis11 .  
2.2) ETIOLOGY 
           TB properly refers only to disease caused by Mycobacterium 
tuberculosis. Similar disease occasionally results from the closely related 
Mycobacteria, M.bovis, M.africanum, and M.microti. 
            TB results almost exclusively from inhalation of airborne particles 
(droplet nuclei) containing M.tuberculosis. They disperse primarily through 
coughing, sneezing and whose sputum contains a significant number of 
organisms (typically enough to render the smear positive). People with 
pulmonary cavitary lesions are especially infectious. Droplet nuclei containing 
tubercle bacilli may remain suspended in room air currents for several hours, 
increasing the chance of spread. However, once these droplets land on a 
surface, it is difficult to resuspend the organisms (eg, by sweeping the floor) as 
respirable particles. Although such actions can resuspend dust particles 
containing tubercle bacilli, these particles are far too large to reach the alveolar 
surfaces necessary to initiate infection12.  
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2.3) EPIDEMIOLOGY 
About one third of the world's population is infected. Of these, perhaps only 15 
million have active disease at any given time. In 2006, an estimated 9.2 million 
new TB cases occurred worldwide (139/100,000). Of these, Africa and 
Southeast Asia each accounted for about 3 million cases, and the Western 
Pacific region for about 2 million. Case rates vary very widely by country, age, 
race, sex, and socioeconomic status. India and China reported the largest 
numbers of new cases, but South Africa has the largest case rate: 940/100,000. 
Epidemiological data on tuberculosis, detect risk factors and other 
epidemiological issues involved in its transmission in some parts of Abia State, 
Nigeria. Sputum samples were collected aseptically from patients in some 
Public hospitals in Abia State. Out of 998 sputum examined, Mycobacterium 
tuberculosis was isolated from 198 (16.83%). Males had higher prevalence of 
infection in each year of study than females. Infection rates remained higher in 
dry season than rainy season in both 2005 and 2006. Traders, public and civil 
servants, police officers, Timber workers, teachers, drivers, students and pupils 
are among the population at risk in Abia State. Out of 198 positive sputum 
samples, 95 (47.97%) were new cases in 2006. This calls for the attention of 
public health workers, governmental and non-government agencies for 
concerted efforts against the disease in this region. 
                   The average prevalence of all forms of tuberculosis in India is 
estimated to be 5.05 per thousand, prevalence of smear-positive cases 2.27 per 
thousand and average annual incidence of smear-positive cases at 84 per 
1,00,000 annually. The Governmental efforts at intervention through Revised 
National Tuberculosis Control Programme (RNTCP) and at monitoring the 
epidemiology of intervention through organising routine reporting are 
highlighted, and data are presented and evaluated on these. RNTCP needs to 
be used as an effective instrument to bring a change in epidemiological 
situation, through fast expansion and achievement of global target12. 
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                An increasing morbidity and mortality from tuberculosis (TB) in the 
near future is forecast for the world at large, with the number of newly 
occurring cases predicted to increase from 7.5 million a year in 1990 to 8.8, 
10.2 and 11.9 million in the years 1995, 2002 and 2005 respectively; an 
increase amounting to 58.6 per cent over a 15-yr period. 
Global epidemiology 
•8 million new cases of disease per year 
•2 million deaths per year 
•80% of new cases live in 22 high burden countries 
•Global health emergency declared by WHO in 1993 
 
              The present review describes the global tuberculosis situation, and 
views it in the context of the goal of the antituberculosis intervention activities. 
It presents the epidemiological situation in India, comments on the current 
trend and discusses the efforts taken towards making projections on the likely 
burden of disease in India over time. 
         2.3.1) Numbers of notifications in England and Wales 1992- 2002 
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2.4) SIGNS AND SYMPTOMS 
 A  bad cough that lasts 3 weeks or longer  
  Pain in the chest  
  Coughing up blood or sputum  
2.4.1) Other symptoms of active TB disease are, 
  Weakness or fatigue  
  Weight loss  
  Loss of appetite  
  Chills  
  Fever  
  Sweating at night. 
2.5) RISK FACTORS 
                   There are number of factors that make people more susceptible to 
TB infections. Worldwide the most important of these is HIV with co-infection 
present in about 13% of cases13. Tuberculosis is closely linked to both 
overcrowding and malnutrition making it one of the principal diseases of 
poverty. Chronic lung disease is a risk factor with smoking more than 20 
cigarettes a day increasing the risk by two to four times and silicosis increasing 
the risk about 30 fold. Other disease states that increase the risk of developing 
tuberculosis include alcoholism and diabetes mellitus (threefold increase). 
Certain medications such as corticosteroids and Infliximab (an anti-αTNF 
monoclonal antibody) are becoming increasingly important risk factors, 
especially in the developed world. There is also a genetic susceptibility for 
which overall importance is still undefined14.  
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2.6) TRANSMISSION 
When people with active pulmonary TB cough, sneeze, speak, sing, or spit, 
they expel infectious aerosol droplets 0.5 to 5 µm in diameter. A single sneeze 
can release up to 40,000 droplets. Each one of these droplets may transmit the 
disease, since the infectious dose of tuberculosis is very low and inhaling 
fewer than ten bacteria may cause an infection15.  
                   People with prolonged, frequent, or intense contact are at 
particularly high risk of becoming infected, with an estimated 22% infection 
rate. A person with active but untreated tuberculosis can infect 10 to 15 other 
people per year. Others at risk include people in areas where TB is common, 
people who inject illicit drugs, residents and employees of high-risk 
congregate settings, medically under-served and low-income populations, 
high-risk racial or ethnic minority populations, children exposed to adults in 
high-risk categories, those who are immunocompromised by conditions such 
as HIV/AIDS, people who take immunosuppressant drugs, and health care 
workers serving these high-risk clients16.  
                Transmission can only occur from people with active not latent TB. 
The probability of transmission from one person to another depends upon the 
number of infectious droplets expelled by a carrier, the effectiveness of 
ventilation, the duration of exposure, and the virulence of the M.tuberculosis 
strain. The chain of transmission can be broken by isolating people with active 
disease and starting effective anti-tuberculous therapy. After two weeks of 
such treatment, people with non-resistant active TB generally cease to be 
contagious. If someone does become infected, then it will take three to four 
weeks before the newly infected person can transmit the disease to others17. 
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2.7) PATHOGENESIS 
About 90% of those infected with M.tuberculosis have asymptomatic, latent 
TB infection (sometimes called LTBI), with only a 10% lifetime chance that a 
latent infection will progress to TB disease. However, if untreated, the death 
rate for these active TB cases is more than 50%. 
              TB infection begins when the mycobacteria reach the pulmonary 
alveoli, where they invade and replicate within the endosomes of alveolar 
macrophages. The primary site of infection in the lungs is called the Ghon 
focus, and is generally located in either the upper part of the lower lobe, or the 
lower part of the upper lobe. Simon foci may also be present. Bacteria are 
picked up by dendritic cells, which do not allow replication, although these 
cells can transport the bacilli to local (mediastinal) lymph nodes. Further 
spread is through the bloodstream to other tissues and organs where secondary 
TB lesions can develop in other parts of the lung (particularly the apex of the 
upper lobes), peripheral lymph nodes, kidneys, brain, and bone. All parts of the 
body can be affected by the disease, though it rarely affects the heart, skeletal 
muscles, pancreas and thyroid18. 
              Tuberculosis is classified as one of the granulomatous inflammatory 
conditions. Macrophages, T lymphocytes, B lymphocytes and fibroblasts are 
among the cells that aggregate to form granulomas, with lymphocytes 
surrounding the infected macrophages. The granuloma prevents dissemination 
of the mycobacteria and provides a local environment for interaction of cells of 
the immune system. Bacteria inside the granuloma can become dormant, 
resulting in a latent infection. Another feature of the granulomas of human 
tuberculosis is the development of abnormal cell death (necrosis) in the center 
of tubercles. To the naked eye this has the texture of soft white cheese and is 
termed caseous necrosis18.  
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            If TB bacteria gain entry to the bloodstream from an area of damaged 
tissue they spread through the body and set up many foci of infection, all 
appearing as tiny white tubercles in the tissues. This severe form of TB disease 
is most common in infants and the elderly and is called miliary tuberculosis. 
People with this disseminated TB have a fatality rate near 100% if untreated. 
However, if treated early, the fatality rate is reduced to about 10%19. 
                 In many people the infection waxes and wanes. Tissue destruction 
and necrosis are balanced by healing and fibrosis. Affected tissue is replaced 
by scarring and cavities filled with cheese-like white necrotic material. During 
active disease, some of these cavities are joined to the air passages bronchi and 
this material can be coughed up. It contains living bacteria and can therefore 
spread the infection. Treatment with appropriate antibiotics kills bacteria and 
allows healing to take place. Upon cure, affected areas are eventually replaced 
by scar tissue18.  
2.8) DISEASE SIMILAR TO TUBERCULOSIS 
 
                     There are many forms of mycobacteria other than M.tuberculosis, 
the tubercle bacillus. Some cause infections that may closely resemble 
tuberculosis, but they usually do so only when an infected person's immune 
system is defective. People who are HIV-positive are a prime example. The 
most common mycobacteria that infect AIDS patients are a group known 
as Mycobacterium avium complex (MAC). People infected by MAC are not 
contagious, but they may develop a serious lung infection that is highly 
resistant to antibiotics. MAC infections typically start with the patient 
coughing up mucus. The infection progresses slowly, but eventually blood is 
brought up and the patient has trouble in breathing. In AIDS patients, MAC 
disease can spread throughout the body, with anemia, diarrhea, and stomach 
pain as common features. Often these patients die unless their immune system 
can be strengthened. Other mycobacteria grow in swimming pools and may 
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cause skin infection. Some of them infect wounds and artificial body parts 
such as a breast implant or mechanical heart valve20. 
2.9) DIAGNOSIS 
 
 
Mycobacterium tuberculosis (stained red) in sputum 
               Tuberculosis is diagnosed definitively by identifying the causative 
organism (M.tuberculosis) in a clinical sample (for example, sputum or pus). 
When this is not possible, a probable although sometimes inconclusive 
diagnosis may be made using imaging (X-rays or scans), a tuberculin skin test 
(Mantoux test), or a, Interferon Gamma Release Assay (IGRA).The main 
problem with tuberculosis diagnosis is the difficulty in culturing this slow-
growing organism in the laboratory (it may take 4 to 12 weeks for blood or 
sputum culture). A complete medical evaluation for TB must include a medical 
history, a physical examination, a chest X-ray, microbiological smears, and 
cultures. It may also include a tuberculin skin test, a serological test. The 
interpretation of the tuberculin skin test depends upon the person's risk factors 
for infection and progression to TB disease, such as exposure to other cases of 
TB or immunosuppression21.   
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           New TB tests have been developed that are fast and accurate. These 
include polymerase chain reaction assays for the detection of bacterial DNA22. 
One such molecular diagnostics test gives results in 100 minutes and is 
currently being offered to 116 low- and middle-income countries at a discount 
with support from WHO and the Bill and Melinda Gates foundation. Another 
such test, which was approved by the FDA in 1996, is the amplified 
mycobacterium tuberculosis direct test (MTD, Gen-Probe). This test yields 
results in 2.5 to 3.5 hours, and it is highly sensitive and specific when used to 
test smears positive for acid-fast bacilli (AFB) 23.  
 
2.10) SCREENING 
 
Mantoux tuberculin skin test  
              Mantoux tuberculin skin tests are often used for routine screening of 
high risk individuals24. Currently, latent infection is diagnosed in a non-
immunized person by a tuberculin skin test, which yields a delayed 
hypersensitivity type response to an extract made from M.tuberculosis. Those 
immunized for TB or with past-cleared infection will respond with delayed 
hypersensitivity parallel to those currently in a state of infection, so the test 
must be used with caution, particularly with regard to persons from countries 
where TB immunization is common25. Tuberculin tests have the disadvantage 
of producing false negatives, especially when the person is co-morbid with 
sarcoidosis, Hodgkin’s lymphoma, malnutrition, or most notably active 
tuberculosis disease. The newer interferon release assays (IGRAs) such as T-
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SPOT.TB and QuantiFERON-TB Gold .In Tube overcome many of these 
problems. IGRAs are in vitro blood tests that are more specific than the skin 
test. IGRAs detect the release of interferon gamma in response to 
mycobacterial proteins such as ESAT-6.These is not affected by immunization 
or environmental mycobacteria, so generate fewer false positive results. There 
is also evidence that IGRAs are more sensitive than the skin test26.  
2.11) TREATMENT 
                Treatment for TB uses antibiotics to kill the bacteria. Effective TB 
treatment is difficult, due to the unusual structure and chemical composition of 
the mycobacterial cell wall, which makes many antibiotics ineffective and 
hinders the entry of drugs27. The two antibiotics most commonly used are 
isoniazid and rifampicin and treatments can be prolonged. Latent TB treatment 
usually uses a single antibiotic, while active TB disease is best treated with 
combinations of several antibiotics, to reduce the risk of the bacteria 
developing antibiotic resistance28. People with latent infections are treated to 
prevent them from progressing to active TB disease later in life. 
         With the advent of effective Antituberculous chemotherapy, it became 
apparent that patients no longer needed sanatorium treatment. Results with 
regimens containing Isoniazid together with P-aminosalicylate (PAS) or 
Ethambutol, and sometimes Streptomycin, gave excellent results. Treatment 
was required for 18-24 months if relapse was to be prevented. The availability 
of Pyrazinamide and, more importantly, Rifampicin made shorter courses of 
treatment possibility. Most regimens in the developed world now contain 
Isoniazid, Rifampicin, and Pyrazinamide, possibly with another agent such as 
Ethambutol. 
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2.12) TREATMENT OF PULMONARY TUBERCULOSIS 
The Joint Tuberculosis Committee recommends a 6 month regimen consisting 
of Rifampicin, Isoniazid, Pyrazinamide and Ethambutol for initial 2 months 
followed by further 4 months of Rifampicin, and Isoniazid. The fourth drug 
(Ethambutol) may be omitted in patients with a low risk of resistance to 
Isoniazid.  
                   2.12.1) Dosing of First-Line Anti-TB Drugs* 
Drug  Adults or 
Children  
Daily†  Once/wk  2 Times/wk  3 Times/wk 
Isoniazid  
INH 
Adults 
(maximum) 
5 mg/kg 
(300 mg) 
15 mg/kg 
(900 mg) 
15 mg/kg 
(900 mg) 
15 mg/kg 
(900 mg) 
Children 
(maximum) 
10–15 
mg/kg    
(300 mg) 
N/A 20–30 
mg/kg    
(900 mg) 
N/A 
Rifampicin Adults 
(maximum) 
10 mg/kg 
(600 mg) 
N/A 10 mg/kg 
(600 mg) 
10 mg/kg 
(600 mg) 
Children 
(maximum) 
10–20 
mg/kg    
(600 mg) 
N/A 10–20 
mg/kg    
(600 mg) 
N/A 
Pyrazinamide Adults 
(whole 
tablets): 
    
40–55 kg 1 g N/A 2 g 1.5 g 
56–75 kg 1.5 g N/A 3 g 2.5 g 
≥ 76 kg§  2 g N/A 4 g 3 g 
Children 
(maximum) 
15–30 
mg/kg        
(2 g) 
N/A 50 mg/kg  
(2 g) 
N/A 
Ethambutol Adults 
(whole 
tablets): 
    
40–55 kg 800 mg N/A 2000 mg 1200 mg 
56–75 kg 1200 mg N/A 2800 mg 2000 mg 
≥ 76 kg§  1600 mg N/A 4000 mg 2400 mg 
Children 
(maximum) 
15–20 
mg/kg        
(1 g) 
N/A 50 mg/kg 
(2.5 g) 
N/A 
*Specific regimens are discussed in text. 
†Daily is considered either 5 or 7 days/wk. All dosing < 7 days/wk must be given as 
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directly observed therapy. 
‡Continuation phase only. 
§Maximum dose. 
N/A = not applicable. 
 
 
 
Isoniazid is the cheapest and one of the most effective antituberculous drugs. 
Its bactericidal potency is equalled only by rifampacin. It acts on the tubercle 
bacilli multiplying in the walls of the cavities, as well as those potent than 
other antituberculous drugs in preventing drug resistance to other drugs. 
Mechanism of action: INH is a prodrug. It is activates by the mycobacterial 
catalase-peroxidase to an active compound which inhibits the synthesis of 
mycolic acid, an important constituent of the mycobacterial cell wall. INH 
inhibits the same catalase-peroxidase and makes the organisms susceptible to 
oxidative mechanisms29. 
Rifampicin is the semisynthetic derivative of rifamycin B, important property 
is its effectiveness against Mycobacterium tuberculosis and Mycobacterium 
leprae. The former organism is inhibited by doses of the same magnitude as 
with INH but the sterlizing action is faster than that of INH.  
Mechanism of action: Rifampicin acts by inhibiting bacterial DNA dependent 
RNA polymerase, thus stopping the expression of bacterial genes. Human 
RNA polymerase is not inhibited. Rifampicin is Bactericidal and acts against 
both intra and extra-cellular organisms. Effective against tubercle bacilli 
resistant to other standard drugs and against some of the atypical 
mycobacteria. The only drug which acts on the persisters29. 
25 
 
Pyrazinamide is chemically related to thiosemicarbazones and nicotinamide, 
is effective orally against Mycobacterium tuberculosis of human type resistant 
to streptomycin and INH but is ineffective against the bovine and atypical 
forms of tubercle bacilli. In combination with streptomycin, INH and 
rifampicin, pyrazinamide exerts a potent sterilizing effect on the tuberculous 
lesions during the first two months of therapy. 
Mechanism of action: Pyrazinamide is not definitely known. It is a prodrug 
and is converted to the active compound pyrazinoic acid. Like INH, it inhibits 
the bacterial synthesis of mycolic acid29. 
Ethambutol is effective orally against mycobacteria resistant to INH, 
Streptomycin and Ethionamide as well as against many atypical mycobacteria. 
Primary resistance to this drug has not been reported. When it is used along 
with other drugs, resistance to ethambutol develops slowly, and the 
development of resistance to the other drugs is greatly delayed. 
Mechanism of action: It acts mainly against rapidly multiplying organisms in 
the walls of the cavities. It inhibits the synthesis of bacterial cell wall 
arabinosyl transferase29. 
2.13) MEDICATION RESISTANCE 
Primary resistance occurs in persons infected with a resistant strain of TB. A 
person with fully susceptible TB develops secondary resistance (acquired 
resistance) during TB therapy because of inadequate treatment, not taking the 
prescribed regimen appropriately, or using low-quality medication30. Drug-
resistant TB is a public health issue in many developing countries, as treatment 
is longer and requires more expensive drugs. Multi-drug-resistant tuberculosis 
(MDR-TB) is defined as resistance to the two most effective first-line TB 
drugs: rifampicin and isoniazid. Extensively drug-resistant TB (XDR-TB) is 
also resistant to three or more of the six classes of second-line drugs. Totally 
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drug-resistance TB (TDR-TB), which was first observed in 2003 in Italy, but 
not widely reported until 2012, is resistant to all currently-used drugs31. 
2.14) ADVERSE EFFECTS OF ANTITUBERCULAR DRUGS 
  
            Tuberculosis is an infectious disease which can be totally cured by 
combining antitubercular drugs. Current therapeutic regimens with isoniazid, 
rifampicin, pyrazinamide, ethambutol, and streptomycin have proved 
successful in treating tuberculosis. However, they are associated to a high rate 
of adverse effects that can lead to therapeutic failure. Understanding the nature 
and the severity of these adverse effects allows for their appropriate 
management. Toxic neuropathy and hepatitis are the most common adverse 
reactions to isoniazid. Rifampicin is generally well tolerated but some severe 
immuno-allergic reactions may occur in case of intermittent regimen. 
Pyrazinamide-induced liver injury is rare but sometimes lethal. Joint 
affections, usually due to hyperuricemia, are more frequent but easily 
manageable. The major adverse effect related to ethambutol is ocular optic 
neuropathy. It occurs dose-dependently and can be irreversible. Finally, 
administration of streptomycin is potentially associated with renal and 
cochleo-vestibular toxicity that might be milder than when induced by other 
aminoglycosides. The management of antituberculosis-induced adverse effects 
depends on parameters related to the adverse effect itself and to the 
administrated drug32. 
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2.15) Supporting Literatures 
McArt DG et al (2009), reported that the single-cell gel electrophoresis 
technique or comet assay is widely regarded as a quick and reliable method of 
analyzing DNA damage in individual cells33. 
Kumaravel TS et al (2006), reported that the length of DNA migration is 
directly related to the loops of released DNA or the size of DNA fragments, 
and is proportional to the amounts of strand breaks and alkali-labile sites34. 
Collins AR et al (1997), reported that the ‘Percentage DNA in the tail’ is the 
second primary comet measurement on which other derived units are based. 
The percentage of DNA in tail is directly proportional to the amount of 
damaged DNA35. 
Gonzalez C et al (2002), reported that certain drugs are known to induce DNA 
damage in healthy cells and potentiate the oxidative stress generated during 
cellular events. Induction of DNA damage in lymphocytes by various 
antibiotics, anaesthetic agents and oral contraceptives have been studied with 
the help of comet assay36. 
Nima V. Thakkar et al (2011), reported that the presence of significant cellular 
damage in diabetic population and diabetic hypothyroid complications as 
compared to hypothyroid patients and normal healthy individuals, which is 
suggestive of detrimental effects of diabetes. The DNA damaging effects of 
drug treatment like sulphonamides can not be ruled out as patients receiving 
glibenclamide showed high Olive Tail Moment (OTM) measurements 
indicating greater possibility of cellular damage. The high level of 
concordance of the results obtained in the comet assay showed that the comet 
assay is not only sensitive enough to detect low levels of DNA damage in 
human lymphocytes, but it is also highly specific and give an idea of diabetes 
control in T2DM individuals37. 
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Kassie F et al (2000), stated that DNA strand breaks allow DNA to extend 
from lysed and salt-extracted nuclei, or nucleoids to form a comet like tail on 
alkaline electrophoresis. The comet assay, a technique, capable of detecting 
DNA damage and repair in individual cells, is a valuable approach for human 
biomonitoring studies38. 
Nima V. Thakkar et al (2010), concluded that cellular damage depends on age 
and duration of disease condition, although dependence of disease conditions 
seems to be a major contributor of the cell damage as indicated by increase in 
the percentage of apoptotic cells in diabetic subjects39.  
De Boeck et al (2000), said that the comet assay has been widely used for 
genotoxic studies and cell biological studies, and even in human biomonitoring 
studies. Among manyparameters of Comet features, the tail parameters that are 
the most frequently used are those of the tail moment, the tail DNA, and the 
tail length40. 
Olive et al (1990a, 1992), introduced that the tail moment and the percentage 
of DNA in the tail (the tail DNA) and these parameters have been used by 
many researchers for genotoxic studies41. 
Bocker et al (1997), reported that the tail moment and tail DNA showed more 
sensitivity than the tail length on the basis of an X-irradiation dose-response 
experiment. Correlation between the tail moment and the tail length of human 
lymphocytes was relatively lower than between the tail moment and the head-
tail ratio, both in normal subjects and in ataxia telangiectasia patients42. 
Eunil Lee et al (2004), stated that the tail moment provides the most stable 
estimates for DNA damage because it has a large degree of uniformity in 
quantile dispersions. To study high degrees of damage from toxic exposure 
using B cells or G cells, however, the tail DNA showed more significant 
discrepancies than the other parameters, in terms of both the mean differences 
and the graphical differences between the two groups43. 
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Semra Sardasa et al (2000), Diabetes patients often show increased production 
of reactive oxidative species (ROS) together with vascular complications. The 
presence of these ROS may lead to increased DNA damage in peripheral blood 
lymphocytes that may be revealed by the comet assay44. 
P Dandona et al (1996), said that the production of reactive oxygen species and 
lipid peroxidation are increased in diabetic patients, especially in those with 
poor diabetic control and hypertriglyceridamia. Mechanisms that contribute to 
the formation of free radicals in diabetics may include not only increased non-
enzymatic and auto oxidative glycoxylation, but also metabolic stress resulting 
from changes in energy metabolism, the levels of inflammatory mediators and 
the status of antioxidant defense45. 
Semra Sardasa et al (2000), study provide evidence of oxidative damage in 
diabetic patients when evaluated by alkaline comet assay. Difference could be 
detected in IDDM and NIDDM patients groups in terms of extent of DNA 
migration. Clinical findings of increased serum levels of lipid peroxides, 
differences in creatinine levels and glycosylated haemoglobin-HbAic values in 
all patients suffering from diabetes mellitus supports the hypothesis that 
enhanced lipid peroxidation contributes to an increased formation of free 
radicals in diabetes mellitus. Cells with migration were at a lower level in non-
smoker patients and a slightly lower level in antioxidant supplemented 
patients46. 
Ostling O et al (1987), said that the ability to measure heterogeneity in 
response to DNA damaging agents was first tested on cells exposed to the 
cancer chemotherapeutic drug, Bleomycin47. 
Peggy L Olive et al (2006), said that the idea was to combine DNA gel 
electrophoresis with Fluorescence microscopy to visualize migration of DNA 
strands from individual agarose-embedded cells. If the negatively charged 
DNA contained breaks, DNA supercoils were relaxed and broken ends were 
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able to migrate towards the anode during a brief electrophoresis. If the DNA 
was undamaged, the lack of free ends and large size of the fragments prevented 
migration. Determination of the relative amount of DNA that migrated 
provided a simple way to measure the number of DNA breaks in an individual 
cells48. 
Olive P.L et al (1990), said that the Comet head containing the high-
molecular-weight DNA and the comet tail containing the leading ends of 
migrating fragments were measured in real time from digitized images using 
software developed for this purpose49. 
K Kalaiselvi et al (2002), said that with the aim of assessing possible genetic 
damage in leprosy patients, we carried out a cytogenetic study involving 
leprosy patients and age-matched controls living in the same area. Peripheral 
blood lymphocytes of the patients and control subjects were analyzed for the 
presence of DNA damage, using single cell gel electrophoresis (the Comet 
assay), and for cytogenetic parameters [chromosomal aberrations (CA) and 
micronucleus (MN) frequency]. The use of CA and MN as markers of early 
biological effects is well established in genotoxicity studies, while the Comet 
assay is a more innovative technique50. 
Guillermo T. Saez et al (1993), reported that the incubation of calf thymus 
DNA in the presence of rifamycin SV induces a decrease in the absorbance of 
DNA at 260 nm. The effect was found to be proportional to the antibiotic 
concentration and enhanced by copper (II) ions. In the presence of rifamycin 
SV and copper (II), a significant increase in thiobarbituric acid-reactive (TBA-
reactive) material is also observed. This effect is inhibited to different degrees 
by the following antioxidants: catalase 77%; thiourea 72%; glutathione (GSH) 
62%; ethanol 52%; and DMSO 34%, suggesting that both hydrogen peroxide 
(H2O2) and hydroxyl radicals (OH·) are involved in DNA damage.  Rifamycin 
SV-copper (II) mixtures were also found to induce the production of 
peroxidation material from deoxyribose and, in this case, glutathione and 
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ethanol were the most effective antioxidant substrates with inhibition rates of 
91% and 88% respectively. Electrophoretic studies show that calf thymus 
DNA becomes damaged after 20 min. Normal DNA electrophoretic pattern 
was found to be preserved by catalase and GSH at physiological 
concentrations and by thiourea. No protection is observed in the presence of 
ethanol or DMSO. The results obtained indicate the involvement of different 
reactive species in the degradation process of DNA due to rifamycin SV-
copper (II) complex and emphasize the role of reduced glutathione as an 
oxygen free radical scavenger51. 
Madhuri Jaju et al (2005), discussed that the genetic consequences of drug 
interaction in tuberculosis patients. Blood from tuberculosis patients was 
cultured before, during, and after withdrawal of therapy involving five 
different drug combinations of isoniazid (INH), thiacetazone (TAZ), para-
aminosalicylic acid (PAS), and streptomycin (SM). The approaches used to 
detect DNA damage were chromosome aberrations and sister chromatid 
exchanges (SCEs). A total of 179 subjects were analyzed.  In combination 
these drugs showed synergistic, additive, and antagonistic effects, though they 
were found to be nonclastogenic individually. Four of the drug combinations, 
INH+TAZ, INH+PAS, INH+TAZ+SM, and INH + PAS + SM, induced a 
significant increase in the frequency of aberrations, whereas INH+SM did not 
induce aberrations. In fact, SM appeared to reduce the frequency of 
aberrations. SCEs were increased in only two patients: one treated with INH + 
TAZ and the other with INH + PAS. The frequency of aberrations after 
withdrawal of therapy was decreased; it was slightly higher than the controls, 
though it was insignificant. Though the drug-induced aberrations do not persist 
after withdrawal of therapy, the chromosome damaging combinations of drugs 
should be used with caution, because the possibility of meiotic chromosome 
damage in germ cells (during therapy), which might be passed on to the next 
generation, cannot be ruled out52. 
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C. Gonzalez et al (2002), reported that the infectious disease and malnutrition 
in children are public health problems in developing countries. Malnutrition is 
associated with higher levels of DNA damage, and this increased damage 
could be due to different factors, including the possibility that cells from 
malnourished children could be more susceptible to environmental damage. 
The aim of this study was to evaluate the susceptibility of lymphocytes from 
malnourished children to DNA damage induced by antibiotics by using the 
comet assay. The same group of malnourished infected children were studied 
before and after a treatment period, and compared to a group of well-nourished 
infected children. Results showed that before and after drug treatment, tail 
length migration was two times greater in malnourished than in well-nourished 
children. The proportion of cells with high damage was also increased in 
malnourished children. Additionally in well-nourished and malnourished 
children, a cell subpopulation (non-damaged cells) more resistant to DNA 
damage induced by antibiotics was observed; this was more prevalent in the 
well-nourished children. Meanwhile, in malnourished children, a cell 
population seems to be more susceptible and reaches higher levels of DNA 
damage. This might help explain the impaired immune response observed in 
malnourished children. The increased DNA migration and the increased 
proportion of cells with higher levels of damage seem to indicate that 
malnourished children are more susceptible to DNA damage induced by 
drugs53. 
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3. AIM & OBJECTIVE 
 
AIM 
To Assess the DNA damage in Pulmonary Tuberculosis patients by Comet 
assay. 
OBJECTIVE 
¾ To assess the DNA fragmentations, 
•          In newly diagnosed Tuberculosis patients 
•          In 3 months treated Tuberculosis patients 
•          In 6 months treated Tuberculosis patients, then 
¾ To determine the extent of cell damage in Tuberculosis patients with the help 
of   comet assay. 
 
¾ To study the influence of Tuberculosis on DNA damage. 
 
¾ To assess the influence of duration of drug treatment on DNA damage. 
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                                   4. PLAN OF WORK 
 
 
     The proposed study was designed as given below, 
¾ Identification of scope of work 
¾ Literature survey 
¾ Preparation of study protocol 
¾ Designing  the proforma 
¾ Obtaining approval from the ethical committee 
¾ Obtaining consent from the Hospital Authority 
¾ Data collection 
o Selection of patients 
o Collection of patients details 
o Collection of blood sample from patient 
¾ Analysis of data.  
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5. METHODOLOGY 
                 
  5.1) Study type: 
                             Prospective study 
  5.2) Study site: 
                             Tiruchengodu Govt. Hospital 
5.3) Sample size: 
                          40 subjects, Total numbers of patients included in the study 
were 30. These 30 patients were selected after screening of all TB patients who 
were visiting TB out patient clinic. All those patients who met with the set 
inclusion criteria constituted the study population. Among these 30 patients, 10 
were newly diagnosed TB patients (G1), 10 were TB patients treated with anti 
TB drugs for 3 months (G2), and 10 were TB patients treated with anti TB 
drugs for 6 months (G3). In order to compare the influence the disease state on 
cell damage, 10 Healthy volunteers (G0) of age and sex match were included 
to assess the cell damage. 
  5.4) Study duration: 
                              8 months  
   5.5) Ethical Clearance:  
                              The proposal was submitted to the Institutional Ethical 
Committee (IEC) of Swamy Vivekanandha College of Pharmacy. The IEC 
permitted to carry out the study dated on 21-09-2011 (IEC/ Sep/2011/07). The 
copy of approval was given in annexure 2. 
 
5.6) Study population: 
                 Newly diagnosed Patients with Tuberculosis based on sputum 
positivity and Tuberculosis patients taking Anti-tubercular drugs and Healthy 
volunteers. 
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5.6.1) Inclusion criteria:  
• Patients taking Anti-tubercular drugs both in intensive and continuation     
phase. 
• Adult TB male / female patients. 
 
5.6.2) Exclusion criteria:  
o Severely ill patients, 
o TB Patients with liver disease, 
o TB Pregnant and lactating, 
o TB Diabetic / cardio vascular disease patients, 
o TB Patients with other comorbid conditions, 
o TB patients with HIV. 
 5.7) Initial Assessment: 
      Patient data entry form was used to record the patient details such as name, 
age, sex, educational status, occupation, social history, family history, dietary 
habits, and treatment regimen for TB. 
5.8) Blood Sample collection: 
             2 ml Blood samples were collected from healthy volunteers and newly 
diagnosed TB patients, Three months treated TB patients, and Six months 
treated TB patients by venipuncture.  
 
 
 
 
 
 
37 
 
5.9) Parameters to be measured: 
               Analysing DNA Damage from blood samples. 
Comet Length, Comet Height, Comet Area, Comet Intensity, Comet Mean 
Intensity, Head Diameter, Head Area, Head Intensity, Head Mean Intensity, 
%DNA in Head, Tail Length, Tail Area, Tail Intensity, Tail Mean Intensity, 
%DNA in Tail, Tail Moment, Olive Tail Moment. 
 
5.10) Single cell gel electrophoresis / Comet assay 
The single cell gel electrophoresis (SCGE)/ comet assay, developed by N.P. 
Singh1, combines the simplicity of biochemical techniques for detecting DNA 
single strand breaks (frank strand breaks and incomplete excision repair sites), 
alkali-labile sites and cross linking with the single cell approach typical of 
cytogenetic assays. The advantages of the SCGE technique include: 
 (1) The collection of data at the level of the individual cell, allowing for more 
robust types of statistical analyses; 
 (2) The need for small numbers of cells per sample (<10,000);  
 (3) Its sensitivity for detecting DNA damage; and 
 (4) That virtually any eukaryotic cell population is amenable to analysis. 
 I. Preparation of Reagents 
Materials:                                                                     Supplier (Catalogue 
Number): 
Dimethylsulfoxide (DMSO)                                          - Qualigens (CPW59) 
Disodium EDTA                                                            - HiMedia (RM1370) 
Ethidium Bromide                                                             - Sigma (E-8751) 
Histopaque                                                                         - Sigma (1077-1) 
Phosphate Buffered Saline (PBS) (Ca++, Mg++ free)      - HiMedia (TS1006) 
Sodium Chloride (NaCl)                                                   - Ranbaxy Rankem 
(S0160) 
Sodium Hydroxide (NaOH)                                             - BDH-Merck (89021) 
Triton X-100                                                                      - HiMedia (RM 845) 
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Trizma Base                                                                       - Spectrochem 
(042061) 
 
 
Procedure: 
 
1. PBS (Ca++, Mg++ free):  Dulbecco's PBS - 1 L packet: add 990 mL dHO, 
adjust pH to 7.4, q.s.(quantity sufficient) to 1000 mL, store at room 
temperature. 
      2. Lysing Solution: Ingredients per 1000 mL:           
   2.5 M NaCl                          146.1 gm 
                                                                                          
  100 mM EDTA                     37.2 gm 
                                                                                        
  10 mM Trizma base              1.2 gm 
 
Add ingredients to about 700 mL dH₂O and begin stirring the mixture. Add ~8 
gm NaOH and allow the mixture to dissolve (about 20 min). Adjust the pH to 
10.0 using concentrated HCl or NaOH. q.s. to 890 mL with dH₂O (the Triton 
X-100 and DMSO will increase the Volume to the correct amount), store at 
room temperature. 
 
Final lysing solution: add fresh 1% Triton X-100 and 10% DMSO, and then 
refrigerate forat least 30 minutes prior to slide addition. 
 
NOTE: The purpose of the DMSO in the lysing solution is to scavenge 
radicals generated by the iron released from hemoglobin when blood or animal 
tissues are used. It is not needed for other situations or where the slides will be 
kept in lysing for a brief time only. 
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 3. Electrophoresis Buffer (300 mM NaOH / 1 mM EDTA): 
 
Prepare from stock solutions:         1. 10 N NaOH (200 g/500 mL dH₂O) 
2. 200 mM EDTA (14.89 g/200 mL      
dH₂O, pH 10) 
 
Store both at room temperature. We prepare the NaOH and EDTA stock 
solutions every ~2 weeks. 
 
For 1X Buffer (made fresh before each electrophoresis run): per liter, add 30 
mL NaOH and 5.0 mL EDTA, q.s. to 1000 mL, mix well. The total volume 
depends on the gel box capacity. 
Prior to use, measure the pH of the buffer to ensure >13. 
 
4. Neutralization Buffer:   0.4 M Tris - 48.5 gm added to ~800 mL dH₂O, 
adjust pH to 7.5 with concentrated (>10 M) HCl: q.s. to 1000 mL with dH₂O, 
store at room temperature. 
 
5. Staining Solution:   Ethidium Bromide (EtBr; 10X Stock - 20 μg/mL): add 
10 mg in 50mL dH₂O, store at room temperature. For 1X stock - mix 1 mL 
with 9 mL dH₂O. 
 
CAUTION: Handle EtBr with adequate precaution as it is known carcinogen. 
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II. Preparation of Slides for the SCGE/Comet Assay 
 
 
Materials:                                                                               Supplier 
(Catalogue Number): 
Normal Melting Agarose (NMA)                                           - HiMedia 
(RM273) 
Low Melting Point Agarose (LMPA)                                     - Sigma (A9414) 
Methanol                                                                                 - Qualigens 
Coverslips (No. 1, 24 x 60 mm)                                              - Blue Star 
Microcentrifuge Tubes                                                            - Tarsons 
(500010) 
Micropipettor and Tips                                                            - Tarsons 
Microscope Slides, Conventional / 
Micro gel electrophoresis (MGE) slides                                 - Blue Label or 
Es Em Inc (NS 0001) 
Coplin jars (opaque)                                                               - Tarsons (480000) 
Horizontal Gel Electrophoresis Apparatus                             -GIBCO BRL, 
Life 
Technologies 
Electrophoresis Power Supply                                                - Techno Source  
  
 
Preparation of base slides 
1. Prepare 1% (500 mg per 50ml PBS) and 0.5% LMPA (250 mg per 50 ml 
PBS) and 1.0% NMA (500 mg per 50 ml in Milli Q water). Microwave or heat 
until near boiling and the agarose dissolves. For LMPA, aliquot 5 mL samples 
into scintillation vials (or other suitable containers) and refrigerate until 
needed. When needed, briefly melt agarose in microwave or by another 
appropriate method. Place LMPA vial in a 37ºC dry/water bath to cool and 
stabilize the temperature. 
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2. Dip the slides in methanol and burn them over a blue flame to remove the 
machine oil and dust. 
 
3. While NMA agarose is hot, dip conventional slides up to one-third the 
frosted area and gently remove (2). Wipe underside of slide to remove agarose 
and lay the slide in a tray on a flat surface to dry. The slides may be air dried or 
warmed at 50ºC for quicker drying. Store the slides at room temperature until 
needed; avoid high humidity conditions. We generally 
prepare slides the day before use. 
 
NOTE: Slides should be labeled before storage. 
 
III. Separation of Lymphocytes and treatment in vitro: 
 
1. 1 ml of blood is taken from a healthy donor by venipuncture. Lymphocytes 
are separated from it using Histopaque-1077. Briefly, blood is diluted 1:1 with 
PBS or RPMI (without FBS) and layered over 600 ul Histopaque and 
centrifuged at 800 X g for 20 minutes. The ‘buffy’ coat is aspirated into 3-5 ml 
of PBS/ RPMI and centrifuged at 250 X g for 10 
minutes to pellet the lymphocytes. The pellet is resuspended in ~1 ml of 
IRPMI and counted over a Haemocytometer. Nearly 2 X 104 cells per 100 μL 
of medium are taken for each dose of the test material. 
 
2. One ml of each dose is made in medium (without FBS) and lymphocytes 
added to it. The eppendorff is inverted to mix the cells and test material. 
 
3. The ependorff-tubes are properly wiped with alcohol and kept in the 
incubator at 37ºC for 3 hours. 
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4. After the treatment, the cells are centrifuged at 3000 rpm for 5 minutes to 
pellet the lymphocytes. The test substance is aspirated and discarded. The 
pellet is then resuspended in 100 ml of PBS & 10 ml removed for trypan blue 
viability test. 
 
5. 100 ml of 1% LMPA is added & 80 ml of the suspension layered onto the 
base slides, and a coverslip is placed on it. Put the slides on ice packs until 
Agarose layer hardens (~5 to 10 min). 
 
6. Gently slide off coverslip and add a third agarose layer (90 μL LMPA) to 
the slide. Replace coverslip and return to the slide tray until the agarose layer 
hardens (~5 to 10 minutes). 
 
7. Remove coverslip and slowly lower slide into cold, freshly made Lysing 
Solution. Protect from light and refrigerate for a minimum of 2 hours. 
 
IV.Electrophoresis of Microgel Slides 
 
The procedure described is for electrophoresis under pH>13 alkaline 
conditions. 
1. After at least 2hour at ~4ºC, gently remove slides from the Lysing Solution. 
Place slides side by side on the horizontal gel box near one end, sliding them 
as close together as possible. 
 
2. Fill the buffer reservoirs with freshly made pH>13 Electrophoresis Buffer 
until the liquid level completely covers the slides (avoid bubbles over the 
agarose). 
 
3. Let slides sit in the alkaline buffer for 20 minutes to allow for unwinding of 
the DNA and the expression of alkali-labile damage. 
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NOTE: The longer the exposure to alkali, the greater the expression of alkali-
labile damage. 
 
4. Turn on power supply to 24 volts (~0.74 V/cm) and adjust the current to 300 
milliamperes by raising or lowering the buffer level. Depending on the purpose 
of the study and on the extent of migration in control samples, electrophorese 
the slides for 30 minutes. 
 
NOTE: The goal is to obtain migration among the control cells without it 
being excessive. 
The optimal electrophoresis duration differs for different cell types. If 
crosslinking is one of the endpoints being assessed then having controls with 
about 25% migrated DNA is useful. A lower voltage, amperage and a longer 
electrophoresis time may allow for increased sensitivity. Different gel boxes 
will require different voltage settings to correct for the distance between the 
anode and the cathode. 
 
5. Turn off the power. Gently lift the slides from the buffer and place on a 
drain tray. Drop wise coat the slides with Neutralization Buffer, let sit for at 
least 5 minutes. Drain slides and repeat two more times.  
 
6. Slides may be stained with 80μL 1X Ethidium Bromide, leave for 5 min and 
then dipped in chilled distilled water to remove excess stain. The coverslip is 
then placed over it and the slides are scored immediately or dried before 
staining as in step 7. 
 
7. Drain slides, keep them for 20 min in cold 100% ethanol or cold 100% 
methanol for dehydration. Air dry the slides and place them in an oven at 50ºC 
for 30 min. Store in a dry area. 
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8. When convenient, rehydrate the slides with chilled distilled water for 30 min 
and stain with EtBr as in step 6 and cover with a fresh coverslip. Before 
viewing slides, blot away excess liquid on the back and edges. After scoring, 
remove coverslip, rinse in 100% alcohol to remove stain, let dry, and store for 
archival purposes if needed. 
 
 
NOTE: Perform steps 1- 4 under yellow / dimmed light. This is to prevent any 
DNA damage that may arise from fluorescent white light. 
 
V.Evaluation of DNA Damage 
 
1. For visualization of DNA damage, observations are made of EtBr-stained 
DNA using a 40x objective on a fluorescent microscope. 
 
2. Although any image analysis system may be suitable for the quantitation of 
SCGE data, we use a Komet 5 image analysis software developed by Kinetic 
Imaging, Ltd. (Liverpool, UK) linked to a CCD camera to assess the 
quantitative and qualitative extent of DNA damage in the cells by measuring 
the length of DNA migration and the percentage of migrated DNA. Finally, the 
program calculates tail moment.  
 
3. The amount of migration per cell, the number of cells with increased 
migration, the extent of migration among damaged cells, and viability. 
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5.11) Statistical Analysis: 
                   The statistical calculation were done using Graph pad Instat 
software version 3.01. The results are expressed as mean ± S.E.M. Difference 
between diseased (TB) and control subjects were assessed using one-way 
ANOVA followed by Tukey-Kramer Multiple Comparison Test. P<0.05 was 
considered as statistically significant. 
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6. RESULTS 
 
Cells in living beings are affected or damaged due to various agents or factors 
such as environmental chemicals, radiations, alcohol, smoking, by producing 
free radicals. All free radicals are normally handled effectively by anti-
oxidants / scavengers like glutathione in our body. However when the free 
radical production is more than the antioxidant in our body, it manifest as 
disease. So we can anticipate cell damage intern DNA damage in diseased 
condition. Various drugs are given in the management of diseases. Since most 
of the drugs are from synthetic source, these chemical substances might induce 
cell damage. Hence this study has been designed to investigate the extent of 
cell damage /DNA damage in tuberculosis patients and also to study anti-
tubercular drug induced cell damage. 
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6.1) Demographic Details of Study population: 
           A total of 40 subjects were included in the study. Out of 40, 10 were 
healthy subjects (G0) and 30 were TB patients with 10 patients are newly 
diagnosed TB patients (G1), 10 patients is three months treatment (G2) and 10 
patients is Six months treatment (G3). The TB Patients were administered the 
prescribed drugs as Directly Observed Therapy Short course in the hospital, 
after their breakfast. 
         Table 1: Demographic details of study population. 
Parameters No. of 
Subjects 
(%) 
    
 G0 (n=10) G1 (n=10) G2 (n=10) G3 (n=10) Total (n=40) 
Sex        
Male 6 (60%) 
 
8 (80%) 6 (60%) 8 (80%) 28 (70%) 
 
Female 4 (40%) 
 
2 (20%) 
 
  4 (40%)  
 
2 (20%) 
 
  12 (30%) 
 
Age      
25-35 yrs 4 (40%) 4 (40%) 4 (40%) 2 (20%) 14(35%) 
36-45 yrs 4 (40%) 2 (20%) 4 (40%) 4 (40%) 14(35%) 
46-55 yrs - 2 (20%) - 2 (20%) 4 (10%) 
56-65 yrs 2 (20%) 2 (20%) 2 (20%) 2 (20%) 8 (20%) 
Education 
Status 
     
Illiterate - 2 (20%) - 2 (20%) 4 (10%) 
Primary 6 (60%) 4 (40%) 6 (60%) 6 (60%) 22 (55%) 
SSLC 4 (40%) 4 (40%) 2 (20%) - 10 (25%) 
HSE - - - 2 (20%) 2(5%) 
UG - - 2 (20%) - 2 (5%) 
Occupation      
Coolie 2 (20%) 6 (60%) 4(40%) 4 (40%) 16(40%) 
Driver 4 (40%) - 2 (20%) - 6 (15%) 
Employee - 4 (40%) 2 (20%) 4(40%) 10 (25%) 
House wife 4 (40%) - 2 (20%) 2 (20%) 8 (20%) 
Smoking 
History 
     
Smoker 2 (20%) 8 (80%) 6 (60%) 6 (60%) 22 (55%) 
Non-smoker 8 (80%) 2 (20%) 4 (40%) 4 (40%) 18 (45%) 
Alcoholism      
Yes 6 (60%) 6 (60%) 6 (60%) 4 (40%) 22 (55%) 
No 4 (40%) 4 (40%) 4 (40%) 6 (60%) 18 (45%) 
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Demographic details of Study population: 
6.1.1) Sex: 
Patients of both sex were included 6 males and 4 females in control group, 8 
males and 2 female in newly diagnosed TB patients, 6 males and 4 females in 
Three months treated TB patients, 8 males and 2 female in Six months treated 
TB patients. Out of 40 patients 28 (70%) were males and 12 (30%) were 
females. It is given in Fig.1 
 
Fig 1: Gender distribution for different groups of study population 
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6.1.2) Age: 
Respondents with 25-65 years of age were included in the study. Out of 40 
Subjects in this study, 14 (35%) were in age group between 25-35 yrs, 14 
(35%) were in age group between 36-45 yrs, 4 (10%) were in age group 
between 46-55yrs and 8 (20%) were in age group between 56-65 yrs were 
included. (Fig.2). 
 
Fig 2: Age distribution for different groups of study population 
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6.1.3) Education status: 
The study population were categorised in to five groups according to their 
educational status:  4 (10%) were Illiterate, 22 (55%) had primary education, 
10 (25%) completed SSLC education, 2 (5%) in Higher Secondary education 
and 2 (5%) were graduates. (Fig.3) 
Fig 3: Educational status for different groups of study population 
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6.1.4) Occupation:  
Out of 40 subjects, 16 (40%) were coolie workers, 6 (15%) were drivers, 10 
(25%) were employees, 8 (20%) were house wives.(Fig 4). 
Fig 4: Occupation for different groups of study population 
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6.1.5) Social History: 
Smoking history: 
Out of 40 Subjects, 22 (55%) are smoker and 18 (45%) are non-smoker. Out of 
30 TB patients, 20 (66.67%) patients are smokers and 10 (33.33%) patients are 
non-smokers. 
Alcoholism: 
Out of 40 Subjects, 22 (55) are alcoholic and 18 (45%) patients are non-
alcoholic. Among 30 TB patients, 16 (53.33%) patients are Alcoholic and 14 
(46.67%) are Non-Alcoholic ( Fig 5). 
 
Fig 5: Social History for different groups of study population 
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6.2) Quantitative analysis of cellular damage: 
The single cell gel electrophoresis technique or comet assay is widely regarded 
as a quick and reliable method of analysing DNA damage in individual cells. 
The whole-cell comet assay results obtained in this current study are 
summarised in table 2. Result of the different comet parameters are given 
below. 
                    Table 2: Impact of Tuberculosis on Comet assay indices 
Parameters G0 G1 G2 G3 P value 
Comet 
length (µm) 
80.476 ± 
3.624 
117.61 ± 
13.68 
175.42 ± 
61.275**   
193.37± 
10.027*** 
 
0.0005*** 
Comet 
height(µm) 
122.676 ± 
65.623 
 
145.19 ± 
9.74 
 
192.586 ± 
47.432 
  
163.848 ± 
14.617 
 
0.2916 
Comet 
Area(µm²) 
1380.292 ± 
119.51  
  
3040.782 ± 
  1726.7 
3490.728 ± 
   900.40 
4333.006 ± 
  1048.4 
0.3221 
Comet 
Intensity 
83.939 ± 
  7.760 
86.148 ±  
1.100 
137.537 ± 
  1.958*** 
84.331 ± 
  1.036 
<0.0001*** 
Comet 
mean 
Intensity 
58.942 ± 
  4.748 
116.074 ±    
9.065*** 
137.704 ±  
10.356*** 
102.998 ±  
1.639 
<0.0001*** 
Head 
diameter(µ
m) 
77.672 ± 
  9.165 
88.796  ± 
12.520 
80.226 ± 
  9.958 
94.646 ± 
  8.537 
0.6287 
Head 
Area(µm²) 
6945.414 ± 
  422.72 
7759.674 ± 
  114.20 
2284.67 ± 
    
542.26*** 
7188.508 ± 
    202.37 
<0.0001*** 
Head 
intensity 
5482.84 ± 
  352.78 
5693.214  ± 
 647.64 
5965.006 ± 
    1064.1 
5653.478 ± 
227.20 
0.9632 
Head Mean 
intensity 
46.676 ± 
  5.973 
80.736 ±  
6.196 
72.238 ±  
11.842 
82.116  ± 
9.190* 
0.0363* 
%DNA in 
head 
92.186 ±  
1.406 
91.734 ±  
1.188 
85.558 ±  
7.036 
83.908  ± 
4.378 
0.421 
Tail 
length(µm) 
5.81  ± 
1.120 
7.712  ± 
0.613 
7.486 ±  
0.770 
5.494 ±  
0.675 
0.1462 
Tail 
Area(µm²) 
30.52  ± 
4.998 
43.122 ±  
6.461 
66.746  ± 
6.896* 
61.624  ± 
9.071* 
0.0075 
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Tail 
intensity 
565.47  ± 
138.60 
274.656 ±   
65.111 
312.856 ± 
29.384 
434.682 ±    
30.022 
0.0774 
Tail mean 
intensity 
361.798 ±  
61.444 
663.144 ±   
157.72 
1001.86 ±   
92.912** 
587.856  ± 
86.700 
0.0051** 
%DNA in 
tail 
2.454 ±  
0.5919 
5.328  ± 
0.6341** 
5.09 ±  
0.4283* 
3.812 ±  
0.4131 
0.0049** 
Tail 
Moment 
0.072 ±  
0.0143 
0.059 ±   
0.009 
0.0686 ± 
0.0085 
0.0582 ± 
0.008 
0.8360 
OTM 0.098  ± 
0.0124 
0.162 ±  
0.0174 
0.234 ±  
0.0457 
0.242  ±  
0.0538 
0.0449* 
 
 
All the data was shown as mean ± S.E.M values. *, **, ***, p< 0.0001: 
Statistically significant difference from controls; (One way ANOVA with post 
test) 
 * considered as significant 
 ** considered as very significant 
 *** considered as extremely significant. 
 ns considered as not significant. 
                 Comet assay of white blood cells of study subjects shows extremely 
significant increase in comet length in TB patients, when compared to control 
group. (G3=193.37; G2=175.42; G1=117.61; G0=80.47; P=0.0005) Similarly 
a significant increase in Comet intensity, Comet mean intensity, Head Area, 
Head mean intensity, Tail Area, tail mean intensity, %DNA in tail and Olive 
tail moment were found in TB patients when compared to control. 
           When a  comparison is made among the TB patients ( G1, G2, G3), Six 
months Anti-tubercular drug treatment exhibited significantly extensive 
damage in DNA than 3 months treated patients and newly diagnosed patients.  
              Some comet parameters like Comet height,  Comet Area, head 
diameter, head intensity, %DNA in head, Tail length, Tail intensity, Tail 
moment showed  increase but not statistically significant.  
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Comet area: The number of pixels in the binary comet image (including 
pixels that belong to fragments) is counted. The area is returned in calibrated 
units.  
Comet intensity: Sums all pixel intensities from the grayscale image when 
there is a corresponding pixel in the binary mask image. The resulting value is 
normalized by the maximum intensity value that can be represented in the data 
buffer. 
Tail moment: The product of distance and normalized intensity integrated 
over the tail length. A damage measure combining the amount of DNA in the 
tail with the distance of migration. 
Tail area: The number of pixels in the binary tail region of image (including 
pixels that belong to fragments) is counted. The area is returned in calibrated 
units. 
Tail length: Tail length is the distance of DNA migration from the body of the 
nuclear core and it is used to evaluate the extent of DNA damage. 
%DNA in Tail: The integrated tail intensity x 100 divided by the total 
integrated cell intensity for a normalized measure of the percent of total cell 
DNA found in the tail. 
Olive Tail moment: Tail moment is defined as the product of the tail length 
and the fraction of total DNA in the tail. Tail moment incorporates a measure 
of both the smallest detectable size of migrating DNA (reflected in the comet 
tail length) and the number of relaxed / broken pieces (represented by the 
intensity of DNA in the tail). 
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COMET ASSAY IMAGE: 
 
 
 
Fig 6 : Comet assay image.Ethidium bromide stained slide when viewed under 
fluorescent microscope at 40x. 
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Table 3: Tukey-Kramer Multiple Comparison test for Comet  
parameters among study population 
 
Parameters Groups Mean Difference q Value P value 
Comet 
Length 
(µm) 
G0  vs G1 
 
G0  vs G2 
 
G0  vs G3 
 
G1  vs G2 
 
G1 vs G3 
 
G2 vs G3 
 
-37.134 
 
-94.950 
 
-112.90 
 
-57.816 
 
-75.764 
 
-17.948 
 
2.279 
 
5.827 
 
6.928 
 
3.548 
 
4.650 
 
1.101 
ns>0.05 
 
<0.01** 
 
<0.001*** 
 
ns>0.05 
 
<0.05* 
 
ns>0.05 
Comet 
intensity 
G0  vs G1 
 
G0  vs G2 
 
G0  vs G3 
 
G1 vs G2 
 
G1 vs G3 
 
G2 vs G3 
 
-2.209 
 
-53.593 
 
-0.3918 
 
-51.389 
 
1.817 
 
53.206 
0.5425 
 
13.162 
 
0.09622 
 
12.620 
 
0.4463 
 
13.066 
ns>0.05 
 
<0.001*** 
 
ns>0.05 
 
<0.001*** 
 
ns>0.05 
 
<0.001*** 
 
Comet 
mean 
intensity 
G0  vs G1 
 
G0  vs G2 
 
G0  vs G3 
 
G1 vs G2 
 
G1 vs G3 
 
G2 vs G3 
 
-57.132 
 
-78.762 
 
-44.056 
 
-21.630 
 
13.076 
 
34.706 
7.799 
 
10.752 
 
6.014 
 
2.953 
 
1.785 
 
4.738 
<0.001*** 
 
<0.001*** 
 
<0.01** 
 
ns >0.05 
 
ns>0.05 
 
<0.05* 
Head Area G0  vs G1 
 
G0  vs G2 
 
G0  vs G3 
-814.26 
 
4660.7 
 
-243.09 
2.244 
 
12.843 
 
0.6699 
ns>0.05 
 
<0.001*** 
 
ns>0.05 
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G1 vs G2  
 
G1 vs G3 
 
G2vs G3 
 
 
547.9 
 
571.17 
 
4903.7 
 
15.087 
 
1.574 
 
13.513 
 
<0.001*** 
 
ns>0.05 
 
<0.001*** 
 
Head mean 
intensity 
G0  vs G1 
 
G0  vs G2 
 
G0  vs G3 
 
G1 vs G2 
 
G1 vs G3 
 
G2 vs G3 
-34.060 
 
-25.562 
 
-35.440 
 
8.498 
 
-1.380 
 
-9.878 
 
3.941 
 
2.958 
 
4.101 
 
0.9833 
 
0.1597 
 
1.143 
ns>0.05 
 
ns>0.05 
 
<0.05* 
 
ns>0.05 
 
ns>0.05 
 
ns>0.05 
Tail area 
(µm²) 
G0  vs G1 
 
G0  vs G2 
 
G0  vs G3 
 
G1 vs G2 
 
G1 vs G3 
 
G2 vs G3 
-12.602 
 
-36.226 
 
-31.104 
 
-23.624 
 
-18.502 
 
5.122 
1.798 
 
5.168 
 
4.437 
 
3.370 
 
2.639 
 
0.7307 
ns>0.05 
 
<0.05* 
 
<0.05* 
 
ns>0.05 
 
ns>0.05 
 
ns>0.05 
 
Tail mean 
intensity 
G0  vs G1 
 
G0  vs G2 
 
G0  vs G3 
 
G1 vs  G2 
 
G1 vs G3 
 
G2 vs G3 
-301.35 
 
-640.06 
 
-226.06 
 
-338.72 
 
75.288 
 
3.912 
 
2.847 
 
6.048 
 
2.136 
 
3.201 
 
0.7114 
 
3.912 
ns>0.05 
 
<0.01** 
 
ns>0.05 
 
ns>0.05 
 
ns>0.05 
 
ns>0.05 
59 
 
%DNA in 
tail 
G0  vs G1 
 
G0  vs G2 
 
G0  vs G3 
 
G1 vs G2 
 
G1 vs G3 
 
G2 vs G3 
 
-2.874 
 
-2.636 
 
-1.358 
 
0.2380 
 
1.516 
 
1.278 
5.464 
 
5.012 
 
2.582 
 
0.4525 
 
2.882 
 
2.430 
 
 
<0.01** 
 
<0.05* 
 
ns>0.05 
 
ns>0.05 
 
ns>0.05 
 
ns>0.05 
Olive Tail 
Moment 
G0  vs G1 
 
G0  vs G2 
 
G0  vs G3 
 
G1 vs G2 
 
G1 vs G3 
 
G2 vs G3 
 
-0.06400 
 
-0.1360 
 
-0.1440 
 
-0.0720 
 
0.0800 
 
0.0080 
 
 
1.734 
 
3.685 
 
3.902 
 
1.951 
 
2.168 
 
0.2168 
ns>0.05 
 
ns>0.05 
 
ns>0.05 
 
ns>0.05 
 
ns>0.05 
 
ns>0.05 
 
The result shown in (Table 2) was analyzes by Tukey-Kramer 
multiple Comparison Test in order to verify the difference between 
the groups.  
      * considered significant 
** considered very significant 
*** considered extremely significant 
ns considered not significant. 
 
            TB patients showed significant increase in Comet length 
when compared to control (P value is 0.0005), when further 
analyzed with Tukey- Kramer Multiple Comparison Test it showed 
no significant difference in G1 compared to G0. Significant 
difference in newly diagnosed TB patients compared to control. 
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Significant difference is observed in TB drug treatment patients ( 
ie), G2 & G3, when compared to G0. 
                 
            TB patients showed significant increase in comet intensity 
when compared to control (P value is <0.0001), when further 
analyzed with Tukey- Kramer multiple Comparison test, it showed a 
significant difference in three months TB drug treatment patients 
compared to control and G1. When three months & six months 
treated Tb patients are compared, six months treated TB patients 
shows extreme significant difference. 
              TB patients showed significant increase in Comet mean 
intensity when compared to control group (P value is <0.0001), 
when further analysed with Tukey- Kramer multiple Comparison 
Test, an extremely significant difference in G1 & G2 when 
compared with G0. When compared with six months and three 
months treated patients, three months treated TB patients showed 
significant difference. 
               TB patients showed significant increase in Head Area 
when compared to control group (P value is <0.0001), when further 
analyzed with Tukey- Kramer Multiple Comparison, three months 
TB drug treatment patients shows extremely significant difference 
when compared with control group. TB drug treatment patients 
showed extremely significant difference when compared to newly 
diagnosed patients. 
                 TB patients showed significant increase in Head mean 
intensity when compared to control group (P value is 0.0363), when 
further analyzed with Tukey- Kramer multiple Comparison test, it 
shows a significant difference in six months treated TB patients 
when compared with control group (G0). 
                TB patients showed significant increase in Tail area when 
compared to control group (P value is 0.0075), when  further 
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analyzed with Tukey-Kramer Multiple Comparison Test it showed, 
no significant difference in G1 compared to G0. Very significant 
difference is observed in three months TB drug treated and six 
months treated TB patients compared to G0. 
                   TB patients showed significant increase in Tail mean 
intensity when compared to control group (P value is 0.0051), when 
further analyzed with Tukey- Kramer Multiple Comparison test it 
showed, very significant difference was observed in G2 group 
compared with G0. And there is no significant difference is 
observed in any other groups.         
                TB patients showed significant increase in %DNA in tail 
when compared to control group (P value is 0.0049), when further 
analyzed with Tukey- Kramer Multiple Comparison test it showed, 
there is very significant difference in newly diagnosed patients and 
three months treated TB patients. No significant difference is 
observed in six months treated TB patients.   
             TB patients showed significant increase in Olive tail 
moment when compared to control group (P value is 0.0449), when 
further analyzed with Tukey- Kramer Multiple Comparison Test it 
showed, there is no significant difference is  observed in all cases.        
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 Table 4: Comparison of the Comet parameters between cases and control 
Param
eters 
G0 G1 G2 G3 P value 
Comet 
Length 
(µm) 
80.47 ± 3.62 
 
117.61 ± 13.68 
 
175.426 ± 
27.587** 
 
193.374± 
10.027*** 
 
 0.0005*** 
 
Tail 
Length 
(µm) 
5.81 ± 1.12 
 
7.712 ± 0.613 
 
7.486 ± 0.770 
 
5.494 ± 
0.675 
 
   0.1462 
 
Head 
Diamet
er (µm) 
77.67 ± 9.16 
 
88.79 ± 12.52 
 
80.226 ± 
9.958 
 
94.646 ± 
8.537 
 
   0.6287 
 
 
The values are expressed as mean ± S.E.M; (One way ANOVA with post test). 
** considered very significant 
*** considered as extremely significant 
 ns considered not significant 
                  During Electrophoresis, the negatively charged DNA fragments 
migrate from the nucleus of each cell towards the anode producing the images 
which appear like comets. A comet thus formed with the tail of the comet 
being directly proportional to the extent of DNA damage in a single cell. 
              Comet length showed statistically significant increase in patients than 
that of control groups. (117.61 ± 13.68; 80.476 ± 3.624), two fold increase in 
comet length was found in three months treated TB patients and more than two 
fold increase in six months treated TB patients group. P value is 0.0005. 
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Fig 7: Comparison of comet parameters between cases and control (ie), Comet 
length, Tail length, Head diameter. 
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Table 5: Comparison of some commonly used metrics in leucocytes in 
tuberculosis subjects with control 
 
Param
eters 
G0 G1 G2 G3 P value 
Tail 
length 
(µm) 
5.81 ± 1.12 
 
7.832  ± 0.613 
 
7.486 ± 0.77 
 
5.494 ± 
0.675 
(0.1462) 
 
%DNA 
in Tail 
2.454 ± 
0.5919 
 
5.328 ± 
0.6341** 
 
5.09 ± 
0.43* 
 
3.812 ± 
0.41 
 
(0.0049**)
 
OTM 0.098 ± 
0.0124 
 
0.162 ± 
0.01744 
 
0.234 ± 
0.045 
 
0.242 ± 
0.054 
 
(0.0449)* 
 
 
 
The values are expressed as mean ± S.E.M; (One way ANOVA with post test) 
** considered very significant, * considered significant, ns considered not 
significant. 
 
 Results of three different parameters namely, tail length, %DNA in tail and 
Olive tail moment have been presented in Table 5. 
 
Tail length: Tail length is the distance of DNA migration from the body of the 
nuclear core, which is related directly to the fragment size and it is expected to 
be proportional to the extent of DNA damage. Newly diagnosed TB patients 
demonstrated non significantly increased tail length values (7.832 ± 0.613) 
when compared to control subjects and drug treated patients (5.81 ± 1.12; 
7.486 ± 0.77; 5.494 ± 0.675). 
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%DNA in tail: It gives an idea regarding the damaged DNA content in 
individual cells, measured as the total intensity of ethidium bromide in each 
comet tail, verified by DNA leached out of the cell when exposed to alkaline 
electrophoretic conditions. It is defined as the ‘ratio of tail optical intensity to 
the sum of tail and head optical intensity’, multiplied by 100. Very significant 
increase in %DNA in tail in newly diagnosed TB patients were observed 
(5.328 ± 0.634) when compared to control group. Three months treated TB 
patients showed significant difference (5.09 ± 0.4283) when compared with 
control group. P value is 0.0049. 
 
Olive tail Moment (OTM): It is defined as the fraction of tail DNA multiplied 
by the distance between the profile centres of gravity for DNA in head and tail. 
OTM incorporates a measure of both the smallest detectable size of migrating 
DNA (reflected in the comet tail length) and the number of relaxed/ broken 
pieces (represented by the intensity of DNA in the tail). OTM was observed to 
be least in controls and highest in Six months treated group, and the difference 
was significant (0.098 ± 0.0124; 0.162 ± 0.0174; 0.234 ± 0.0457; 0.242 ± 
0.0538). P value is o.0449. 
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Fig 8: Comparison of some commonly used comet parameters are Tail length, %DNA 
in tail, OTM-Olive tail moment.  
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Table 6: Qualitative evaluation of cell damage in tuberculosis patients 
             The number of cells >C1 were found increased in G2 and G3 group 
patients. Although the G1 group patients did not show any significant changes 
when compared with Control (G0) group at p value <0.0001.   
 G0 G1 G2 G3 P value 
C0 52.09 ± 4.72 
 
34.36 ± 3.510** 
 
13.216 ± 
2.46*** 
 
11.2 ± 1.49*** < 0.0001 
C1 26.38 ± 
2.21 
 
47.6 ± 4.659** 
 
64.84 ± 
3.83*** 
 
75.29 ± 3.36*** 
 
< 0.0001 
>C1 1.02 ± 0.25 
 
1.73 ± 0.33  
 
12.88 ± 
1.63*** 
 
15.31 ± 1.74*** 
 
< 0.0001 
 
The values are expressed as mean ± S.E.M ;( One way ANOVA with post 
test). 
Co=undamaged cells, C1=Mild and moderate cells, >C1= High Damage cells 
** considered very significant  
*** considered extremely significant 
The result was shown in ( Table 6 and fig 8) p value was found to be extremely 
significant for C0, C1, and >C1 in all the four groups (ie), Control, Newly 
diagnosed TB patients, Three months treated TB patients and Six months 
treated Tb patients. 
      White blood cells of study subjects were used for comet assay. When the 
cells were viewed through Fluorescent microscope, the field showed both 
damaged and undamaged cells. The numbers of undamaged cells are 
significantly more in healthy volunteers when compared to newly diagnosed 
Tuberculosis patients. (52.09 ± 4.720; 34.36 ± 3.510; p<0.0001). Undamaged 
cells were very much decreased in six months drug treated group than three 
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months drug treated and newly diagnosed patients. (11.2 ± 1.495; 13.21 ± 
2.467; 34.3 ± 3.510; p<0.0001). 
                      Mild to moderately damaged cells were less in number in healthy 
subjects and showed significant increase in diseased patients, and showed 
greater increase in TB drug treated patients (Table 6). 
              Similarly, highly damaged cells also were very high when compared 
to control subjects and TB patients before the initiation of treatment. The study 
results indicate the influence of Mycobacterium tuberculi bacilli infection and 
the impact of anti-tubercular drugs on cell damage.  
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Fig 9: Cellular damage pattern (all the data are shown in mean ± S.E.M values. 
C0= undamaged cells, C1= mild and moderate cells, >C1= highly damaged 
cells.  
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Table 7: Comparison of sex for Comet length and its significance 
                  The comparison of both male and female sex groups, the comet 
length shows extremely significant difference in G2 group, when compared 
with the control group. And in G3 group shows very significant difference 
when compared with the Control group in male patients. P value is <0.0003. 
Female patients didn’t show any significant difference in all groups, when 
compared with control. 
Sex G0 G1 G2 G3 P value 
Male 85.09 ± 
2.63 
120.82 ± 
17.17 
 
203.53 ± 
12.56*** 
 
189.17 ± 
11.75** 
 
0.0003*** 
Female 73.55 ± 
5.53 
 
104.74 ± 0.00 
 
133.26 ± 
64.60 
 
210.16 ± 
0.00 
 
ns 
               
 
                 *** considered extremely significant 
     **considered very significant 
      ns considered not significant 
           
Fig 10: Comparison of sex for Comet length and its significance 
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Table 8: Comparison of Alcoholism for comet length and its significance 
                Comparison of both the Alcoholic and non-alcoholic group, comet 
length shows very significant difference in both three months treated TB 
patients and in six months treated TB patients when compared with control 
group in Alcoholism. P value is <0.0010. And in Non-alcoholic group didn't 
shows any significant differences in all groups when compared with G0 group. 
Parameters G0 G1 G2 G3 P value 
Alcoholic 85.09 ± 
2.63 
106.54 ± 
13.49 
 
203.53 ± 
12.56** 
 
179.99 ± 
25.56** 
 
0.0010*** 
Non-
alcoholic 
73.55 ± 
5.53 
 
134.20 ± 
29.46 
 
133.26 ± 
64.60 
 
202.91 ± 
7.24 
 
ns 
 
*** considered extremely significant 
** considered very significant 
ns considered not significant 
Fig 11: Comparison of Alcoholism for comet length and its 
significane
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                                            7. DISCUSSION 
                 
                The importance of studying DNA damage has been recognized by 
many scientists. Subjects with Healthy volunteers (G0), newly diagnosed TB 
patients (G1), Three months treated TB patients (G2), Six months treated TB 
patients(G3) were included in the present study. Age and long duration of 
disease are two such factors which contribute to the development of DNA 
damage and thereby cell damage (Fournie GJ et al.1993)54. Thus, the present 
study may help us to identify the extent of cellular damage in individuals 
suffering from the Bacterial infectious disease. It can also help to identify the 
effect of the medication on reactive oxygen species generation and thereby 
DNA damage  
                   The cellular damage in TB patients may also occur due to the 
environmental conditions, Food intake, Social history, allergic substances, also 
some chemical substances and radiations. Humans are continuously exposed to 
genotoxic chemicals which can damage the DNA. Today it is well known that 
DNA damaging effects of chemical agents are associated with mutagenic and 
carcinogenic events, which could be the starting point for the development of 
Cancer (Pitot and Dragan et al.1994) 55. Comet assay are useful combination 
when testing for the potential DNA damaging effects of chemicals (Maria 
Andersson et al. 2006)56. 
                   Ionizing radiation produces DNA damage by direct hits. Free 
radical production is an important aspect of ionizing radiation. In addition to 
the other effects, free radicals also cause DNA damage. (Anderson et 
al.2000)57. The mechanistic studies (Curtis et al .1988) have shown that 
micronucleus formation may be due to free radical generation from an agent 
leading to lipid peroxidation of membrane causing the breakage of the DNA 
and covalently binding between the product of lipid peroxidation and DNA. 
The free radicals play an important role in a number of biological processes, 
some of which are necessary for life, such as intercellular killing of bacteria by 
neutropil granulocytes and also in certain cell signalling process58. 
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     The earlier study suggests that the Rifampacin has damaging effect on the 
DNA and this damage may be induced by free radicals generated by this drug 
(O. Awodele et al. 2010) 59.        
                   In the present study, it is attempted to define the most reliable 
comet measurements that would truly reflect the extent of DNA damage 
induced by the bacterial infectious disease. And was assessed by performing 
the alkaline comet assay on peripheral blood samples of the patients. Measure 
of number of highly damaged cells (>C1), Mild and moderate damaged cells 
(C1) and undamaged cells (C0) formed the qualitative evaluation. In this study, 
it was found that percentage of highly damage cells (>C1) was significantly 
high in numbers in Three months treated TB patients and in Six months treated 
TB patients. These results show that Mycobacterium tuberculi infection may 
contribute towards early cell damage of these patients. 
                   The length of DNA migration commonly referred as the Tail 
length (it is measured from the centre of the head to the end of the tail) is the 
first comet measurement outcome used to quantify DNA damage. The length 
of DNA migration is directly related to the loops of released DNA or the size 
of DNA fragments and is proportional to the amount of strand breaks and 
alkali labile sites (Kumaravel TS et al. 2006)60. The difference observed in the 
increase tail length in the Tuberculosis patients when compared to control was 
insignificant. The percentage DNA in the tail is the second primary comet 
measurement on which other derived units are based. The percentage DNA in 
tail is directly proportional to the amount of damaged DNA (Collins AR et al 
1997) 35. 
               Olive tail moment (OTM) is the tail moment the product of the tail 
length and the fraction of total DNA in the tail. Tail moment incorporates a 
measure of both the smallest detectable size of migrating DNA (reflected in the 
comet tail length) and the number of relaxed / broken pieces (represented by 
the intensity of DNA in the tail). A significant difference of (P value is 
0.0449), control group was compared with newly diagnosed, three months, and 
six months. Any change in the level of DNA damage will be reflected most 
73 
 
accurately by Olive tail moment measurements. Increase in Olive tail moment 
in our study confirms the role of Mycobacterial infection on DNA damage.  
             (Patricia C et al. 2011) have analyzed the expression following DNA 
damage in M.tuberculosis of a number of other genes which are DNA damage 
inducible in Escherichia coli. While many of these genes were also induced by 
DNA damage in M.tuberculosis, some were not. In addition, one gene (ruvC) 
which is not induced by DNA damage in E.coli was induced in M.tuberculosis, 
a result likely linked to its different transcriptional arrangement in 
M.tuberculosis2. The repair of DNA damage is expected to be particularly 
important to intracellular pathogens such as Mycobacterium tuberculosis, and 
so it is of interest to examine the response of M. tuberculosis to DNA damage. 
The expression of recA, a key component in DNA repair and recombination, is 
induced by DNA damage in M. Tuberculosis (Brooks PC et al. 2011) 2. 
               The mean± S.E.M value of comet length in control group of patient 
was 80.476 ± 3.624, for newly diagnosed TB patients it was117.61 ± 13.689, 
for Three months treated patients it was 175.426 ± 27.587 and for Six months 
treated patients193.374± 10.027 which was found to be extremely significant 
(P value 0.0005). Comet length showed extremely significant difference 
among the cases when compared with control subjects indicating increased 
DNA damage among cases and this is inconsistent with other studies.                   
               The comet length shows significant difference in Alcohol 
consumption and smokers, it is greater in males taking anti-tubercular drug 
treatment when compared with females, which clearly indicates the influence 
of alcohol induced oxidative stress on cell damage. Oxidative stress and DNA 
damage are increased in pulmonary tuberculosis patients. Increased oxidative 
stress associated DNA damage may be one of the pathogenetic mechanisms 
involved in the disorders suggested to be associated with pulmonary 
tuberculosis. (Sahbettin Selek et al.2011)5. 
               Certain drugs are known to induce DNA damage in healthy cells and 
potentiate the oxidative stress generated during cellular events (Gonzalez c et 
al 2002)36. To the best of our knowledge, no study has been performed to 
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understand the effect of anti-tubercular drugs on cell damage with the help of 
comet assay. It was observed that Six months treated Tuberculosis patients 
taking anti-tubercular drug treatment of Rifampacin and Isoniazid showed an 
extremely significant cellular damage. And in three months treated Tb patients 
taking anti-tubercular drugs like Rifampacin, Isoniazid, Pyrazinamide, and 
Ethambutol also showed a significant difference in cellular damage. Major 
anti-TB drugs include isoniazid (INH), Rifampacin (RMP), and Ethambutol 
(EMB). The co-administration of Rifampacin and antioxidants (Vit.C & Vit. 
E) has protective effect on the damaging potentials of Rifampacin on the DNA. 
It may then be recommended that the clinician may incorporate antioxidants in 
the regimen of patients with tuberculosis so as to reduce the possible adverse 
effect on the DNA (O.Awodele et al 2010)59. 
                Thus, in the light of our observation, it is suggested that Tuberculosis 
patients showed increased DNA damage as significant differences were 
detected between Control, newly diagnosed TB patients, Three months treated 
TB patients and Six months treated TB patients in terms of frequencies of 
damaged cells. The result of the present study reveal that patients undergoing 
therapy had significantly greater DNA damage as compared with untreated 
patients, indicating that bacterial infection and drug therapy are causal factors.  
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8. SUMMARY & CONCLUSION 
 
• In conclusion, the present study suggest the presence of significant cellular 
damage in Six months treated tuberculosis patients and in three months treated 
tuberculosis patients compared with normal healthy individuals, which is 
suggestive of detrimental effects of tuberculosis.  
• Further, the DNA damaging effects of anti-tubercular drugs like Rifampacin 
and Isoniazid showed greater possibility of cellular damage.  
• Extent of cell damage is high in males when compared with females, due to 
adduction of Alcohol and smoking.  
• The high level of concordance of the result obtained in the comet assay showed 
that the comet assay is not only sensitive enough to detect low levels of DNA 
damage in human lymphocytes, but it also highly specific and give an idea  
about how the anti-tubercular  drugs causes DNA damage to the human. 
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